Abridge
Abridge raised US$2.3M in Seed funding.
Email and contact information
Company website: remedium-bio.com/
Decision maker info and email: SIGNUP TO UNBLOCK
Headquarters: Needham, Massachusetts (United States)
Industry: Biotechnology, Health Care, Therapeutics
Business model:
Funding
- Total funding amount: $2,300,000 (in USD)
- Estimated valuation: $11,500,000.00
- Latest deal type: Seed
- First fundind year: 2022
Growth
Founders: Francesco Luppino, Frank Luppino
Top investors: MicroVentures, Longevitytech.fund, Angel Star Ventures, Primo Medical Group, Guindy Alumni Angels
Team size: SIGNUP TO UNBLOCK
Revenue: SIGNUP TO UNBLOCK